A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Recruiting	Phase 1	2026-08-20		NCT07738614

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eli Lilly and Company	370

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
ICON Early Phase Services	San Antonio	United States	1
Lilly Centre for Clinical Pharmacology	Singapore	Singapore	12

Clinical trials